Rightway hits $1.1B valuation with Khosla-led round
March 31, 2021
Healthtech startup Rightway has raised $100 million at a $1.1 billion valuation. Khosla Ventures led the Series C round, with Thrive Capital, Tiger Global and others also participating. New York-based Rightway makes software to help people navigate the healthcare system and pharmacy benefits. The startup raised $20 million in 2019.